Artículos de revistas sobre el tema "Xenograft tumors"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Xenograft tumors".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Siu, I.-Mei, Vafi Salmasi, Brent A. Orr, Qi Zhao, Zev A. Binder, Christine Tran, Masaru Ishii, Gregory J. Riggins, Christine L. Hann y Gary L. Gallia. "Establishment and characterization of a primary human chordoma xenograft model". Journal of Neurosurgery 116, n.º 4 (abril de 2012): 801–9. http://dx.doi.org/10.3171/2011.12.jns111123.
Texto completoSicklick, Jason Keith, Stephanie Yvette Leonard, Evangeline Mose, Randall P. French, Michele Criscuoli, Dawn V. Jaquish, Karly Maruyama, Richard B. Schwab, David Cheresh y Andrew M. Lowy. "A novel xenograft model of gastrointestinal stromal tumors." Journal of Clinical Oncology 30, n.º 4_suppl (1 de febrero de 2012): 202. http://dx.doi.org/10.1200/jco.2012.30.4_suppl.202.
Texto completoDavies, Jason M., Aaron E. Robinson, Cynthia Cowdrey, Praveen V. Mummaneni, Gregory S. Ducker, Kevan M. Shokat, Andrew Bollen, Byron Hann y Joanna J. Phillips. "Generation of a patient-derived chordoma xenograft and characterization of the phosphoproteome in a recurrent chordoma". Journal of Neurosurgery 120, n.º 2 (febrero de 2014): 331–36. http://dx.doi.org/10.3171/2013.10.jns13598.
Texto completoPham, Khoa, Allison R. Hanaford, Brad A. Poore, Micah J. Maxwell, Heather Sweeney, Akhila Parthasarathy, Jesse Alt et al. "Comprehensive Metabolic Profiling of MYC-Amplified Medulloblastoma Tumors Reveals Key Dependencies on Amino Acid, Tricarboxylic Acid and Hexosamine Pathways". Cancers 14, n.º 5 (3 de marzo de 2022): 1311. http://dx.doi.org/10.3390/cancers14051311.
Texto completoKijima, Noriyuki, Yoshikazu Nakajima, Daisuke Kanematsu, Tomoko Shofuda, Yuichiro Higuchi, Hiroshi Suemizu, Kanji Mori et al. "TMOD-29. ESTABLISHMENT OF PATIENT-DERIVED XENOGRAFTS FROM RARE PRIMARY BRAIN TUMORS". Neuro-Oncology 22, Supplement_2 (noviembre de 2020): ii234. http://dx.doi.org/10.1093/neuonc/noaa215.979.
Texto completoDougherty, Mark, Eric Taylor y Marlan Hansen. "TMET-34. RADIATION METABOLOMICS IN PRIMARY HUMAN MENINGIOMA AND SCHWANNOMA: EARLY EXPERIENCE AND INITIAL RESULTS". Neuro-Oncology 24, Supplement_7 (1 de noviembre de 2022): vii269. http://dx.doi.org/10.1093/neuonc/noac209.1039.
Texto completoDong, Yiyu, Brandon Manley, A. Ari Hakimi, Jonathan A. Coleman, Paul Russo y James Hsieh. "Comparing surgical tissue versus biopsy tissue in the development of a clear cell renal cell carcinoma xenograft model." Journal of Clinical Oncology 34, n.º 2_suppl (10 de enero de 2016): 519. http://dx.doi.org/10.1200/jco.2016.34.2_suppl.519.
Texto completoBreij, Esther CW, David Satijn, Sandra Verploegen, Bart de Goeij, Danita Schuurhuis, Wim Bleeker, Mischa Houtkamp y Paul Parren. "Use of an antibody-drug conjugate targeting tissue factor to induce complete tumor regression in xenograft models with heterogeneous target expression." Journal of Clinical Oncology 31, n.º 15_suppl (20 de mayo de 2013): 3066. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.3066.
Texto completoLukbanova, E. A., M. V. Mindar, E. A. Dzhenkova, A. Yu Maksimov, A. S. Goncharova, Yu S. Shatova, A. A. Maslov, A. V. Shaposhnikov, E. V. Zaikina y Yu N. Lazutin. "Experimental approach to obtaining subcutaneous xenograft of non-small cell lung cancer". Research and Practical Medicine Journal 9, n.º 2 (4 de mayo de 2022): 65–76. http://dx.doi.org/10.17709/2410-1893-2022-9-2-5.
Texto completoDobbin, Zachary C., Ashwini A. Katre, Angela Ziebarth, Monjri Shah, Adam D. Steg, Ronald David Alvarez, Michael G. Conner y Charles N. Landen. "Use of an optimized primary ovarian cancer xenograft model to mimic patient tumor biology and heterogeneity." Journal of Clinical Oncology 30, n.º 15_suppl (20 de mayo de 2012): 5036. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.5036.
Texto completoZhang, Libo, Douglass C. Vines, Deborah A. Scollard, Trevor McKee, Teesha Komal, Milan Ganguly, Trevor Do et al. "Correlation of Somatostatin Receptor-2 Expression with Gallium-68-DOTA-TATE Uptake in Neuroblastoma Xenograft Models". Contrast Media & Molecular Imaging 2017 (2017): 1–10. http://dx.doi.org/10.1155/2017/9481276.
Texto completoLiu, C., L.-H. Dai, D.-Q. Dou, L.-Q. Ma y Y.-X. Sun. "A natural food sweetener with anti-pancreatic cancer properties". Oncogenesis 5, n.º 4 (abril de 2016): e217-e217. http://dx.doi.org/10.1038/oncsis.2016.28.
Texto completoJeuken, Judith W. M., Sandra H. E. Sprenger, Pieter Wesseling, Hans J. J. A. Bernsen, Ron F. Suijkerbuijk, Femke Roelofs, Merryn V. E. Macville, H. Jacobus Gilhuis, Jacobus J. van Overbeeke y Rudolf H. Boerman. "Genetic reflection of glioblastoma biopsy material in xenografts: characterization of 11 glioblastoma xenograft lines by comparative genomic hybridization". Journal of Neurosurgery 92, n.º 4 (abril de 2000): 652–58. http://dx.doi.org/10.3171/jns.2000.92.4.0652.
Texto completoHossain, Jubayer A., Md A. Latif, Lars A. R. Ystaas, Sandra Ninzima, Kristoffer Riecken, Arnaud Muller, Francisco Azuaje et al. "Long-term treatment with valganciclovir improves lentiviral suicide gene therapy of glioblastoma". Neuro-Oncology 21, n.º 7 (8 de abril de 2019): 890–900. http://dx.doi.org/10.1093/neuonc/noz060.
Texto completoChen, Bao-An, Ya-nan Wu, Jian Cheng, Feng Gao, Wen-lin Xu, Hui-lin Shen, Jia-hua Ding et al. "Mechanism Research of Reversal of Multidrug Resistance by the Application of 5-Bromotetrandrine and Magnetic Nanoparticle of Fe3O4 Combined with Daunorubicin in a Human-Nude Mice Xenograft Model". Blood 112, n.º 11 (16 de noviembre de 2008): 5058. http://dx.doi.org/10.1182/blood.v112.11.5058.5058.
Texto completoBradford, Leslie Siriya, Jose Alejandro Rauh-Hain, Rachel Marie Clark, Jolijn W. Groeneweg, Ling Zhang, Celeste M. DiGloria, Darrell R. Borger et al. "Targeting the PI3K signaling cascade in PIK3CA mutated endometrial cancer in a primary human xenograft model." Journal of Clinical Oncology 31, n.º 15_suppl (20 de mayo de 2013): e13564-e13564. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.e13564.
Texto completoAl-Gizawiy, Mona M., Robert T. Wujek, Casey J. Zoss, Ryuma Tanaka, Shama P. Mirza, Christopher R. Chitambar y Kathleen M. Schmainda. "HGG-06. CHARACTERIZATION OF THE EFFECT OF THE ORAL IRON-MIMETIC GALLIUM MALTOLATE ON PEDIATRIC GLIOBLASTOMA GROWTH IN VIVO". Neuro-Oncology 25, Supplement_1 (1 de junio de 2023): i39. http://dx.doi.org/10.1093/neuonc/noad073.155.
Texto completoFerragu, Matthieu, Luisa Vergori, Vincent Le Corre, Sarah Bellal, Maria del Carmen Martinez y Pierre Bigot. "Effects of Large Extracellular Vesicles from Kidney Cancer Patients on the Growth and Environment of Renal Cell Carcinoma Xenografts in a Mouse Model". Current Issues in Molecular Biology 45, n.º 3 (17 de marzo de 2023): 2491–504. http://dx.doi.org/10.3390/cimb45030163.
Texto completoAl-Gizawiy, Mona, Robert T. Wujek, Casey J. Zoss, Ryuma Tanaka, Shama P. Mirza, Christopher R. Chitambar y Kathleen M. Schmainda. "ATRT-03. THE ORAL IRON-MIMETIC GALLIUM MALTOLATE INHIBITS ATRT IN VIVO – IMAGING AND HISTOLOGICAL CHARACTERIZATION". Neuro-Oncology 25, Supplement_1 (1 de junio de 2023): i1. http://dx.doi.org/10.1093/neuonc/noad073.003.
Texto completoPark, Jun Won, Hyejin Um, Hanna Yang, Joo Young Cha, Kyoung-June Lee y Hark K. Kim. "CWP232291, a Wnt/β-catenin inhibitor, to suppress the growth and development of gastrointestinal cancers." Journal of Clinical Oncology 35, n.º 15_suppl (20 de mayo de 2017): e15534-e15534. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.e15534.
Texto completoDucker, Gregory S., Chloe Evelyn Atreya, Jeffrey Simko, Eric K. Nakakura, Emily K. Bergsland, David B. Donner, Kevan M. Shokat y Robert S. Warren. "Effect of PIK3CA and KRAS mutations on sensitivity to ATP-competitive mTOR inhibitors in a primary xenograft model of colorectal carcinoma." Journal of Clinical Oncology 30, n.º 4_suppl (1 de febrero de 2012): 483. http://dx.doi.org/10.1200/jco.2012.30.4_suppl.483.
Texto completoComeaux, Evan, Wenwei Lin, Taosheng Chen, Burgess Freeman y Charles G. Mullighan. "PI3K and MEK Inhibition in Hypodiploid Acute Lymphoblastic Leukemia". Blood 128, n.º 22 (2 de diciembre de 2016): 1635. http://dx.doi.org/10.1182/blood.v128.22.1635.1635.
Texto completoHe, Fei, Xiongming Zhou, Gan Huang, Qingkun Jiang, Li Wan y Jiaxuan Qiu. "Establishment and Identification of Patient-Derived Xenograft Model for Oral Squamous Cell Carcinoma". Journal of Oncology 2022 (5 de septiembre de 2022): 1–7. http://dx.doi.org/10.1155/2022/3135470.
Texto completoZhang, Huiyuan, Lin Qi, Yuchen Du, L. Frank Huang, Frank K. Braun, Mari Kogiso, Yanling Zhao et al. "Patient-Derived Orthotopic Xenograft (PDOX) Mouse Models of Primary and Recurrent Meningioma". Cancers 12, n.º 6 (5 de junio de 2020): 1478. http://dx.doi.org/10.3390/cancers12061478.
Texto completoJohn, T., M. Li, D. Panchal, F. Hui, F. Meng, B. Bandarchi-Chamkhaleh, D. Kohler, C. Zhu, F. A. Shepherd y M. Tsao. "Correlation of primary tumor engraftment in immune deficient mice and relapse rate in patients with early-stage non-small cell lung carcinoma (NSCLC)". Journal of Clinical Oncology 27, n.º 15_suppl (20 de mayo de 2009): 11082. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.11082.
Texto completoChen, Selby, Timothy Peterson, S. Keith Anderson, Jeanette Eckel-Passow, Paul A. Decker, Jann Nagina Sarkaria y Ian F. Parney. "Genotypes of human glioma xenografts compared with glioma stem cell-derived tumors." Journal of Clinical Oncology 31, n.º 15_suppl (20 de mayo de 2013): 2072. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.2072.
Texto completoSingh, Kanika, Negar Jamshidi, Roby Zomer, Terrence J. Piva y Nitin Mantri. "Cannabinoids and Prostate Cancer: A Systematic Review of Animal Studies". International Journal of Molecular Sciences 21, n.º 17 (29 de agosto de 2020): 6265. http://dx.doi.org/10.3390/ijms21176265.
Texto completoCarter, W. B. y M. Sekharam. "Human chorionic gonadotropin (HCG) induction of apoptosis in breast cancer". Journal of Clinical Oncology 24, n.º 18_suppl (20 de junio de 2006): 10658. http://dx.doi.org/10.1200/jco.2006.24.18_suppl.10658.
Texto completoLogié, Armelle, Philippe Boudou, Liliane Boccon-Gibod, Eric Baudin, Gilles Vassal, Martin Schlumberger, Yves Le Bouc y Christine Gicquel. "Establishment and Characterization of a Human Adrenocortical Carcinoma Xenograft Model*". Endocrinology 141, n.º 9 (1 de septiembre de 2000): 3165–71. http://dx.doi.org/10.1210/endo.141.9.7668.
Texto completoJanjigian, Yelena Yuriy, Robert Mazgaj, Gregory Carbonetti, Laura H. Tang, Blake Hefter, David Paul Kelsen, Elisa de Stanchina y Vivian E. Strong. "Establishment of primary gastric and gastroesophageal (GE) junction xenografts: A model for characterizing disease heterogeneity." Journal of Clinical Oncology 30, n.º 4_suppl (1 de febrero de 2012): 51. http://dx.doi.org/10.1200/jco.2012.30.4_suppl.51.
Texto completoRotermund, Arne, Martin S. Staege, Sarah Brandt, Jana Luetzkendorf, Henrike Lucas, Lutz P. Mueller y Thomas Mueller. "Luciferase Expressing Preclinical Model Systems Representing the Different Molecular Subtypes of Colorectal Cancer". Cancers 15, n.º 16 (16 de agosto de 2023): 4122. http://dx.doi.org/10.3390/cancers15164122.
Texto completoLiu, C., Y. Liu, D. Chen, Z. Tang, W. Pan, J. Wery y Y. Chen. "Establishment of human primary non-small cell lung cancer xenograft models for test of cytotoxic and targeted anticancer drugs". Journal of Clinical Oncology 27, n.º 15_suppl (20 de mayo de 2009): 11008. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.11008.
Texto completoZhao, Yunqi, Ran Chen, Yun Wang y Yixin Yang. "α-Pinene Inhibits Human Prostate Cancer Growth in a Mouse Xenograft Model". Chemotherapy 63, n.º 1 (26 de octubre de 2017): 1–7. http://dx.doi.org/10.1159/000479863.
Texto completoWang, Hexuan, Michael D. Nieskoski, Kayla Marra, Jason R. Gunn, Stuart B. Trembly, Brian W. Pogue y Marvin M. Doyley. "Elastographic Assessment of Xenograft Pancreatic Tumors". Ultrasound in Medicine & Biology 43, n.º 12 (diciembre de 2017): 2891–903. http://dx.doi.org/10.1016/j.ultrasmedbio.2017.08.008.
Texto completoFederico, Sara Michele, Elizabeth Stewart, Rachel Christine Brennan, Cori Bradley, Fan Wang, Burgess B. Freeman, Clinton F. Stewart, Jianrong Wu y Michael A. Dyer. "Comprehensive preclinical testing for neuroblastoma using orthotopic xenografts of a patient tumor." Journal of Clinical Oncology 30, n.º 15_suppl (20 de mayo de 2012): e13584-e13584. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.e13584.
Texto completoPham, Khoa, Brad Poore, Allison Hanaford, Micah J. Maxwell, Heather Sweeney, Akhila Parthasarathy, Jesse Alt et al. "OTME-9. Comprehensive Metabolic Profiling Of high MYC Medulloblastoma Reveals Key Differences Between In Vitro And In Vivo Glucose And Glutamine Usage". Neuro-Oncology Advances 3, Supplement_2 (1 de julio de 2021): ii15. http://dx.doi.org/10.1093/noajnl/vdab070.060.
Texto completoWinter, Gordon, Andrea B. F. Koch, Jessica Löffler, Mika Lindén, Christoph Solbach, Alireza Abaei, Hao Li, Gerhard Glatting, Ambros J. Beer y Volker Rasche. "Multi-Modal PET and MR Imaging in the Hen’s Egg Test-Chorioallantoic Membrane (HET-CAM) Model for Initial In Vivo Testing of Target-Specific Radioligands". Cancers 12, n.º 5 (15 de mayo de 2020): 1248. http://dx.doi.org/10.3390/cancers12051248.
Texto completoLabitzky, Vera, Anke Baranowsky, Hanna Maar, Sandra Hanika, Sarah Starzonek, Ann-Kristin Ahlers, Katrin Stübke et al. "Modeling Spontaneous Bone Metastasis Formation of Solid Human Tumor Xenografts in Mice". Cancers 12, n.º 2 (7 de febrero de 2020): 385. http://dx.doi.org/10.3390/cancers12020385.
Texto completoIwanicki, Isabella J., Lydia Wu, Fernando Flores-Guzman, Connor Centner, Kenneth B. Bader y Sonia Hernandez. "Histotripsy significantly decreases tumor viability in neuroblastoma xenograft model". Journal of the Acoustical Society of America 152, n.º 4 (octubre de 2022): A248. http://dx.doi.org/10.1121/10.0016165.
Texto completoKim, Jihee, Ji Hyeong Seo, Yun-Hee Kim, YoHan Woo, Yeon Jee Lee, Yena Kim, Wonyoung Choi et al. "Abstract 6042: Developing patient-derived organoids and tumor xenograft model for ovarian cancer for preclinical therapeutic evaluation". Cancer Research 82, n.º 12_Supplement (15 de junio de 2022): 6042. http://dx.doi.org/10.1158/1538-7445.am2022-6042.
Texto completoRamachandran, Cheppail, Gilda M. Portalatin, Adriana M. Prado, Karl-Werner Quirin, Enrique Escalon y Steven J. Melnick. "In Vivo Antitumor Effect of Supercritical CO2 Extract of Mango Ginger (Curcuma amada Roxb) in U-87MG Human Glioblastoma Nude Mice Xenografts". Journal of Evidence-Based Complementary & Alternative Medicine 22, n.º 2 (19 de julio de 2016): 260–67. http://dx.doi.org/10.1177/2156587216659390.
Texto completoCobb, Dustin A., Lixia Liu, Barbara Dziegielewska, Philip Mollica, Maria Lee y Daniel W. Lee. "Abstract 577: Control of solid tumors by alphav beta3 CAR T cells is accompanied by profound tumor penetration and prevention of metastasis in pre-clinical models". Cancer Research 82, n.º 12_Supplement (15 de junio de 2022): 577. http://dx.doi.org/10.1158/1538-7445.am2022-577.
Texto completoTatman, Philip, Tadeusz Wroblewski, Anthony Fringuello, Sam Scherer, William Foreman, Denise Damek, Samy Youssef, Kevin Lillehei, David Ormond y Michael Graner. "DDRE-43. SCREENING OF FDA-APPROVED COMPOUNDS FOR THE TREATMENT OF CHORDOMA, WITH IN VIVO VALIDATION USING THREE DIFFERENT XENOGRAFT MODELS, IDENTIFIES BRIGATINIB AS A POTENTIAL TREATMENT". Neuro-Oncology 23, Supplement_6 (2 de noviembre de 2021): vi83—vi84. http://dx.doi.org/10.1093/neuonc/noab196.327.
Texto completoCharmsaz, Sara, Kirrilee J. Miller, Bryan W. Day, Fares El-Ajeh, Varghese Palath, Geoff T. Yarranton, Christopher R. Bebbington, Andrew M. Scott, Martin Lackmann y Andrew W. Boyd. "Immunotherapeutic Targeting of EphA3". Blood 124, n.º 21 (6 de diciembre de 2014): 3720. http://dx.doi.org/10.1182/blood.v124.21.3720.3720.
Texto completoTateishi, Kensuke, Nobuyoshi Sasaki, Masahito Kawazu, Yohei Miyake, Taishi Nakamura, Yukie Yoshii, Yuko Matsushita et al. "TB-02 NF-KB CANONICAL PATHWAY ACTIVATION DRIVES GLYCOLYSIS AND TUMOR PROGRESSION IN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA". Neuro-Oncology Advances 1, Supplement_2 (diciembre de 2019): ii10. http://dx.doi.org/10.1093/noajnl/vdz039.045.
Texto completoDerenzini, Massimo, Lorenzo Montanaro, Alessandra Chillà, Elena Tosti, Claudio Ceccarelli, Fabio Dall'Olio, Dietmar Öfner y Davide Treré. "Evaluation of Thymidylate Synthase Protein Expression by Western Blotting and Immunohistochemistry on Human Colon Carcinoma Xenografts in Nude Mice". Journal of Histochemistry & Cytochemistry 50, n.º 12 (diciembre de 2002): 1633–40. http://dx.doi.org/10.1177/002215540205001207.
Texto completoTanaka, Tomohito, Ruri Nishie, Shoko Ueda, Shunsuke Miyamoto, Sousuke Hashida, Hiromi Konishi, Shinichi Terada et al. "Endometrial Cancer Patient-Derived Xenograft Models: A Systematic Review". Journal of Clinical Medicine 11, n.º 9 (6 de mayo de 2022): 2606. http://dx.doi.org/10.3390/jcm11092606.
Texto completoJi, Xiwei, Xiangrui Meng, Qingfeng He, Xiaoqiang Xiang, Yufei Shi y Xiao Zhu. "Foretinib Is Effective against Triple-Negative Breast Cancer Cells MDA-MB-231 In Vitro and In Vivo by Down-Regulating p-MET/HGF Signaling". International Journal of Molecular Sciences 24, n.º 1 (1 de enero de 2023): 757. http://dx.doi.org/10.3390/ijms24010757.
Texto completoHuang, Jianzhong, Jason S. Frischer, Tamara New, Eugene S. Kim, Anna Serur, Alice Lee, Angela Kadenhe-Chiwishe et al. "TNP-470 promotes initial vascular sprouting in xenograft tumors". Molecular Cancer Therapeutics 3, n.º 3 (1 de marzo de 2004): 335–43. http://dx.doi.org/10.1158/1535-7163.335.3.3.
Texto completoSuvilesh, Kanve Nagaraj, Yulia I. Nussbaum, Vijay Radhakrishnan, Yariswamy Manjunath, Diego M. Avella, Kevin F. Staveley-O’Carroll, Eric T. Kimchi et al. "Abstract 267: Xenograft models of non-metastatic non-small cell lung cancer reveals micrometastasis-associated single cell composition". Cancer Research 82, n.º 12_Supplement (15 de junio de 2022): 267. http://dx.doi.org/10.1158/1538-7445.am2022-267.
Texto completo